| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/09/1997 | US5665728 Administering rapamycin |
| 09/09/1997 | US5665720 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 09/09/1997 | US5665713 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 09/09/1997 | US5665553 Methods for determining and modulating cellular redox potential and genotoxic states |
| 09/09/1997 | US5665328 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/09/1997 | CA2133966C Ocular androgen therapy in sjogren's syndrome |
| 09/04/1997 | WO1997032046A1 Method and composition for hair removal |
| 09/04/1997 | WO1997032033A1 Compositions and methods of making embryonic stem cells |
| 09/04/1997 | WO1997031931A1 A novel disintegrin metalloprotease and methods of use |
| 09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 09/04/1997 | WO1997031640A1 Combination therapy for osteoporosis |
| 09/04/1997 | WO1997031637A1 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence |
| 09/04/1997 | WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis |
| 09/04/1997 | WO1997031629A1 Treatment of sleep disorders |
| 09/04/1997 | WO1997031546A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 09/04/1997 | CA2247827A1 A novel disintegrin metalloprotease and methods of use |
| 09/04/1997 | CA2247502A1 Compositions and methods of making embryonic stem cells |
| 09/04/1997 | CA2247138A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 09/04/1997 | CA2245871A1 Treatment of sleep disorders |
| 09/03/1997 | EP0792649A1 Treatment of sleep disorders |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | EP0792371A1 Combination method for acne treatment |
| 09/03/1997 | EP0792366A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 09/03/1997 | EP0792359A1 Transcription factor e2f-4 |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792163A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 09/03/1997 | EP0792154A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 09/03/1997 | EP0792147A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
| 09/03/1997 | EP0792145A1 Transdermal resorption of active substances from supercooled masses |
| 09/03/1997 | EP0792137A1 Antifungal treatment of nails |
| 09/03/1997 | CN1158570A Use of aromatase inhibitors in the prepn. of a drug for treating a relative androgend effciency in men |
| 09/03/1997 | CN1158568A 2,3-dihydro-1-1(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines |
| 09/03/1997 | CN1158567A Compositions for the treatment of skin disorders |
| 09/02/1997 | US5663346 Enzyme inhibitors |
| 09/02/1997 | US5663292 Antagonist peptides; regulation of secretion of corticotropin |
| 09/02/1997 | US5663208 Pyruvic acid comppounds, antioxidants and fatty acids |
| 09/02/1997 | US5663188 Synergistic therapeutic compositions of angiotensin I converting enzyme inhibitors and angiotensin II antagonists and methods |
| 09/02/1997 | US5663187 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| 09/02/1997 | US5663186 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| 09/02/1997 | US5663169 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 09/02/1997 | US5663167 Antipsychotic composition and method of treatment |
| 09/02/1997 | US5663059 Polynucleotide with code, gene expression |
| 09/02/1997 | US5662941 Method for treating diseases caused by bacterial microorganisms with a composition containing fluorine F- and lithium LI+ |
| 09/02/1997 | US5662934 Vitamins, gemfibrozil |
| 09/02/1997 | US5662927 Sequential adminitration of drugs for estrogen and progesterone and packages |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | US5662896 Directly administering a vector construct which directs the expression of antitumor agents |
| 09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
| 08/28/1997 | WO1997031113A1 Cell-based assay |
| 08/28/1997 | WO1997030969A1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
| 08/28/1997 | WO1997030716A1 Anti-helicobacter vaccine complex |
| 08/28/1997 | WO1997030713A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/28/1997 | WO1997030704A2 Use of carbonic anhydrase inhibitors for treating macular edema |
| 08/28/1997 | WO1997030701A2 Pharmaceutical compositions for the treatment of glaucoma |
| 08/28/1997 | WO1997030697A1 Method of treating alopecia |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
| 08/28/1997 | WO1997019679A3 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 08/28/1997 | WO1997009068A3 Interactive molecular conjugates |
| 08/28/1997 | DE19608278A1 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie Pharmaceutical preparations containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and radiology interventioniellen |
| 08/28/1997 | CA2247461A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/28/1997 | CA2247258A1 Method of treating alopecia |
| 08/28/1997 | CA2247253A1 Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes and their use in tumour therapy and interventional radiology |
| 08/28/1997 | CA2246300A1 Cell-based assay |
| 08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0791054A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 08/27/1997 | EP0791053A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0790830A1 Trophinin and trophinin-assisting proteins |
| 08/27/1997 | EP0767660A4 Methods and formulations for modulating the human sexual response |
| 08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 08/27/1997 | CN1158085A Composition alleviating pain, containing a non-napcotic and an analgesia enhancer |
| 08/26/1997 | US5661182 Binding hemoglobin with allosteric modifier in blood containing normal amounts of serum albumin |
| 08/26/1997 | US5661179 Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof |
| 08/26/1997 | US5661145 Treating or preventing atherosclerosis or reducing plasma cholesterol levels |
| 08/26/1997 | US5661141 19-oxygenated steroids as therapeutic agents |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5660861 Effective therapy for epilepsies |
| 08/26/1997 | US5660837 Preparing pharmaceutical formulation in form of oil-in-water emulsion |
| 08/26/1997 | US5660835 Method of treating adenosine depletion |
| 08/26/1997 | US5660829 Process for antibody directed enzyme prodrug therapy |
| 08/26/1997 | US5660826 Administering to reduce or delay some of toxic effects of endotoxins or cytokines |
| 08/26/1997 | US5660813 Method of screening of angiotens in II type I receptor antagonists |
| 08/26/1997 | CA1339346C Recombinant chimeric vaccine |
| 08/21/1997 | WO1997030149A1 Novel era |
| 08/21/1997 | WO1997030089A1 Novel antibody-cytokine fusion protein, and methods of making and using the same |
| 08/21/1997 | WO1997030070A1 Novel compounds |
| 08/21/1997 | WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | WO1997030027A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
| 08/21/1997 | WO1997029776A1 Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
| 08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | WO1997029774A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | WO1997029763A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
| 08/21/1997 | WO1997029751A1 Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents |
| 08/21/1997 | WO1997029739A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 08/21/1997 | WO1997029735A1 Dermal penetration enhancers and drug delivery systems involving same |
| 08/21/1997 | WO1997007136A3 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 08/21/1997 | CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |